On June 18, 2013, the FDA issued a warning letter to Herbs of Light, Inc., following an inspection of the company's facility and website, which found statements made about the company's products, including Agrimony, Blood Root, Brown Seaweed, Deer Tick Defense, Echinacea, False Unicorn, Goldenseal, Himalayan Crystal Salts Capsules, Holy Basil, Kidney/Bladder Blend, Lobelia, Mandrake, Olive Leaf, Moringa Botanical Multi-Vitamin, Resistant Microbes, Smoke Out, Thuja, Veins Assist, Vitex, White Oak Bark, Yarrow and Yeast Away to be drug claims. 

For example, Herbs of Light's Echinacea/ Goldenseal was promoted with statements such as, "Strengthens immune system by stimulating production of white blood cells, and may be beneficial in reducing sub-acute, chronic, mucous membrane inflammation." 

(See ConsumerLab.com's Review of Echinacea Supplements for tests of related products).

Moringa Botanical Multi-Vitamin was promoted with statements such as, "Its content of Anti-Bacterials, 36 Anti-inflammatories, Hypotensive and Anticancer Phytochemicals makes it a true Miracle Tree for the World." 

(See ConsumerLab.com's Review of Multivitamin and Multimineral Supplements for tests of related products.)

Living Foods Brown Seaweed was promoted for cancer and thyroid disease with statements such as, "Recommended for: Thyroid Problems: Underactive or overactive." 

(See ConsumerLab.com's Reviews of Greens and Whole Foods Powders and Pills and Kelp Supplements for tests of related products.)

Agrimony, Brown Seaweed, Deer Tick Defense, False Unicorn, Goldenseal, Himalayan Crystal Salts Capsules, Holy Basil, Kidney/Bladder Blend, Olive Leaf, Moringa Botanical Multi-Vitamin, Resistant Microbes, Thuja, Vitex, White Oak Bark, Yarrow and Yeast Away products were also found to be misbranded because the labels do not provide adequate information about the products' intended uses. 

In addition, all Herbs of Light products listed above were found to be adulterated because they were were prepared, packed, or held under conditions that do not meet the Current Good Manufacturing Practices regulations for dietary supplements.

These violations include failure to establish specifications for each component of the dietary supplements the company manufactures, failure to establish and follow written procedures for manufacturing operations and failure to collect and hold reserve samples of each lot of packaged and labeled dietary supplements that were distributed, as required by federal regulations.

To read the FDA's warning letter, use the link below.